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Abstract
The enzymes of the transsulfuration pathway, cystathionine b-synthase (CBS) and cystathionine c-lyase (CSE),
are important for the endogenous production of hydrogen sulfide (H2S), a gaseous signaling molecule. The
relative contributions of CBS and CSE to H2S generation in different tissues are not known. In this study, we
report quantification of CBS and CSE in murine liver and kidney and their contribution to H2S generation in
these tissues and in brain at saturating substrate concentrations. We show that CBS protein levels are signifi-
cantly lower than those of CSE; 60-fold and 20-fold in liver and kidney, respectively. Each enzyme is more
abundant in liver compared with kidney, twofold and sixfold for CBS and CSE, respectively. At high substrate
concentrations (20mM each cysteine and homocysteine), the capacity for liver H2S production is approximately
equal for CBS and CSE, whereas in kidney and brain, CBS constitutes the major source of H2S, accounting for
*80% and *95%, respectively, of the total output. At physiologically relevant concentrations of substrate, and
adjusting for the differences in CBS versus CSE levels, we estimate that CBS accounts for only 3% of H2S
production by the transsulfuration pathway enzymes in liver. Antioxid. Redox Signal. 15, 363–372.
Recognized previously as a poison for aerobic organ-isms, H2S has recently emerged as amember of the family
of gaseous signaling molecules and appears to modulate a
variety of cellular processes (6, 12, 19, 22). H2S induces
opening of ATP-sensitive potassium channels and relaxation
of vascular smooth muscle cells (41), regulates the sensitivity
of N-methyl-d-aspartate receptor, and increases synaptic
transmission in hippocampal neurons (1), reduces myocardial
ischemia/reperfusion injury (8), inhibits cell proliferation
(39), reduces mitochondrial respiration, and induces a sus-
pended animation–like metabolic state (4). Despite the varied
physiological effects attributed to H2S, little clarity exists on
H2S levels and production capacity in tissues, and H2S con-
centrations varying over a 105-fold range have been reported
in biologic samples [reviewed in (28)]. Furthermore, mecha-
nisms that regulate H2S production and clearance are not
known. The primary sources of endogenously produced H2S
are two enzymes in the transsulfuration pathway, CBS and
CSE, which catalyze H2S biogenesis via condensation of cys-
teine and homocysteine and desulfhydration of cysteine,
respectively (33). Although the combined actions of 3-
mercaptopyruvate sulfurtransferase and cysteine amino-
transferase, involved in the cysteine catabolic pathway are
proposed to contribute to H2S production (32), these reactions
can lead to H2S release only in the presence of a reductant (16,
26) (Fig. 1A). The metabolic removal of H2S occurs in the
mitochondrion where H2S is oxidized to thiosulfate (14) and
the electrons are transferred to the electron-transport chain to
generate energy (5, 13). Thiosulfate is further metabolized to
sulfate, a major secreted end product of H2S metabolism (3).
The canonic role of the transsulfuration pathway is to clear
homocysteine, a toxic intermediate in the methionine cycle,
and to divert it to cysteine synthesis (Fig. 1A) (43). CBS is a
heme protein that catalyzes the PLP-dependent b-replacement
of serine by homocysteine to form cystathionine (Fig. 1A) (18).
The second enzyme in the transsulfuration pathway, CSE,
which also is PLP dependent, catalyzes the a,c-elimination of
cystathionine to form cysteine and a-ketobutyrate and am-
monia. CBS also catalyzes an alternative b-replacement of
cysteine by homocysteine (Fig. 1B, reaction iii), at an ap-
proximately fourfold faster rate than the corresponding one
between serine and homocysteine, owing in part to the better
leaving-group potential of H2S versus H2O. In addition, the
lack of reaction stringency allows CBS to catalyze H2S pro-
duction via other reactions, including b-replacement of
cysteine by water, to give serine (Fig. 1B, reaction i), and
b-replacement of cysteine by a second mole of cysteine (re-
action ii), albeit less efficiently (33). Detailed kinetic analyses
suggest that among these reactions, b-replacement of cysteine
by homocysteine is primarily responsible for H2S production
by CBS under both maximal velocity and physiologic sub-
strate concentrations (33).
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CSE is even more versatile in terms of its reactivity be-
cause it can work at both the b-and c-carbons of substrates
generating H2S via a multitude of reactions from cysteine
and homocysteine [i.e., a,b-elimination of cysteine to give
pyruvate (Fig. 1B, reaction i,), b-replacement of cysteine by a
second cysteine (reaction ii), a,c-elimination of homo-
cysteine to give a-ketoglutarate (reaction v), c-replacement
of homocysteine by cysteine (reaction iii), or c-replacement
of homocysteine by a second mole of homocysteine (reac-
tion iv) (7)]. Under maximal-velocity conditions, the c-re-
placement of homocysteine by a second mole of
homocysteine (reaction iv) constitutes the most efficient
H2S-producing reaction. However, kinetic simulations at
physiologically relevant substrate concentrations indicate
that the a,b-elimination of cysteine (reaction i) is the pre-
ferred route for H2S generation by CSE (7). H2S production
by CSE is sensitive to homocysteine concentrations, and
under conditions of hyperhomocysteinemia, the H2S-
generating activity of CSE shifts toward condensation of
two moles of homocysteine. The product of this reaction,
homolanthionine, has been detected in urine samples of
homocystinuria patients (30).
FIG. 1. Schematic of H2S-generation (A) and H2S-generating reactions catalyzed by CBS and CSE (B) in the transsul-
furation pathway (black arrows). GSH, glutathione; CAT, cysteine aminotransferase; MST, 3-mercaptopyruvate sulfur-
transferase.
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The relative contributions of CBS and CSE to total H2S
production in different tissues are not known. Simulations
based on detailed in vitro kinetic analyses predict that if
(a) CBS and CSE are present at equimolar concentrations,
and (b) CBS is fully activated by its allosteric regulator S-
adenosylmethionine (AdoMet), then CBS will be the primary
source ofH2S at physiologically relevant substrate concentrations.
Under such conditions, the ratio of CBS to CSE-derived H2S
is simulated to be *7:3 (33). However, tissue-specific dif-
ferences in the relative CBS and CSE expression levels
would result in one or the other enzyme being the more
prominent source of H2S generation, leading to significant
deviations from the computed ratio. For instance, in brain,
the CBS is assumed to be the major contributor to H2S
generation because of its high expression level relative to
CSE (1). This is consistent with the observation that in the
CSE knockout mouse, brain H2S levels were unchanged. In
contrast, serum H2S levels and the rate of H2S production in
aorta and heart were significantly reduced, suggesting that
CSE is the primary source of H2S generation in peripheral
tissues (40).
Although the activities of CBS and CSE in the transsul-
furation pathway have been reported in different tissues from
various species, the relative quantities of these proteins in
each tissue are not known. Kidney and brain exhibit twofold
to threefold and fivefold to 25-fold lower CBS activity, re-
spectively, compared with liver (9, 25, 37). Similarly, kidney
and brain exhibit about threefold and ‡ 500-fold lower CSE
activity, respectively, than does liver (9, 25). However, direct
comparison of CBS and CSE activities between tissues cannot
be made from the reported data because of differences in
substrate concentrations used for activity measurements.
In this study, we used quantitative Western blot analysis to
determine the relative protein expression levels of CBS and
CSE in murine liver and kidney and demonstrate that it is
tissue dependent. We also determined the H2S production
rate by murine liver, kidney, and brain in the presence and
absence of a CSE inhibitor, propargylglycine, and CBS acti-
vator, AdoMet, which allows dissection of the CSE contri-
bution to the total H2S pool. This study interrogates, for the
first time, the relative contributions of the preferred H2S-
generating reactions catalyzed by CBS and CSE (in the pres-
ence of cysteine and homocysteine) versus previous studies
that have focused on the desulfhydration of cysteine, which
overestimates the contribution of CSE.
Materials and Methods
Animals and tissue collection
Male Balb/c mice (7 to 10 weeks old) were purchased from
the Jackson Laboratory (Bar Harbor, ME). Animals were kil-
led in a CO2 atmosphere, and liver, kidney, and brain were
collected immediately, frozen in liquid nitrogen, and stored at
- 80C until further use. All procedures for animal handling
were performed in accordance with the protocols approved
by the University’s Committee on Use and Care of Animals.
Antibody production and purification
Polyclonal anti-human CBS and anti-human CSE chicken
antibodies were developed in Aves Labs, Inc. (OR) against the
respective recombinant human proteins purified in our lab-
oratory, as described previously (36, 42). The proteins, which
were > 95% pure, were separated on denaturing 10% poly-
acrylamide gels, and the CBS and CSE bands were excised
and used as antigens. Total IgY from each henwas purified by
using either CBS or CSE affinity columns prepared with
the Actigel-ALD kit (Sterogene), according to the vendor’s
protocol.
Western blot analysis
Frozen tissues were powdered in liquid nitrogen by using a
porcelain mortar and pestle, and the powder was suspended
in lysis buffer (100mM sodium phosphate, pH 7.4, containing
0.2% Triton X-100, 1mM b-mercaptoethanol, and 1% protease
inhibitor cocktail (Sigma), 25lg/ml phenylmethylsulfonyl
fluoride, 10lg/ml leupeptin, 20lg/ml aprotinin), and incu-
bated on ice for 30min followed by centrifugation at 14,000 g
for 10min at 4C. The protein concentration in tissue extracts
was determined by using the Bradford assay and bovine se-
rum albumin as a standard. Proteins were resolved on 10%
sodium dodecylsulfate (SDS)-polyacrylamide gels and trans-
ferred to polyvinylidene fluoride (PVDF) membranes. Blots
were probed with polyclonal anti-CBS or anti-CSE chicken
antibodies. Secondary anti-chicken antibodies conjugated
with horseradish peroxidase (Aves) were used (1:50,000 di-
lution), and signals were visualized by using the chemilumi-
nescent peroxidase substrate kit SuperSignal West Dura
(Thermo Scientific).
Quantification of liver and kidney CBS
and CSE levels with Western blot analysis
Recombinant human CBS was purified as described pre-
viously (15). Dr. Taurai Chiku (University ofMichigan) kindly
provided the recombinant human CSE used in this study. For
quantitative Western blot analysis, each gel contained four
lanes in which purified recombinant CBS or CSE of known
amount was loaded, along with varying amounts of tissue
samples, to generate a standard curve from each blot. The
Western blot band density of the purified recombinant pro-
teins was used to generate the standard curve, and the protein
concentration was precisely determined by total amino acid
analysis (Protein Structure Core Facility, University of Ne-
braska Medical Center). Western blot signals were quantified
by using Image J software. The signal intensities of individual
tissue samples were quantified by using the coefficient ob-
tained from the standard curve generated by using purified
proteins.
H2S-production assays
Frozen mouse tissue was disrupted by using a glass ho-
mogenizer in 100mM HEPES, pH 7.4, to obtain a tissue con-
centration of 200mg/ml. Reactions for H2S production were
prepared in polypropylene syringes, as described previously
(11). Tissue homogenate (425 ll), homocysteine, and/or cys-
teine were mixed in 5-ml syringe barrels in a total reaction
volume of 500 ll. For CSE inhibition experiments, tissue ex-
tracts were preincubated with 3mM propargylglycine (PPG)
for 3min at room temperature before the addition of sub-
strates. For CBS activation experiments, AdoMet was added
to a final concentration of 500lM. Syringes were sealed with
plungers and made anaerobic by flushing the headspace with
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nitrogen 5 times by using a three-way stopcock, and then left
in nitrogen in a final total volume (aqueous +gas) of 5ml.
Syringes were placed in an incubator at 37C with gentle
shaking (75 rpm) for 20min. Control reactions, in which buf-
fer replaced tissue homogenate, were prepared in parallel.
Aliquots of 0.1 to 0.3ml from the gas phase of the reaction
syringes were collected by using gas-tight syringes through a
septum attached to the stopcock, and injected in an HP 6890
gas chromatograph (GC) (Hewlett Packard) equipped with a
DB-1 column (30m · 0.53mm · 1.0 lm). The carrier gas (heli-
um) flow rate was 1ml/min, and a temperature gradient
ranging from 30C to 110C over a 20-min period was used.
For samples with a high concentration of H2S, a 10-fold di-
lutionwith nitrogenwas used to prevent column overloading.
H2S was detected by using a 355 sulfur chemiluminescence
detector (Agilent).
The H2S standard was obtained from Cryogenic Gases
(Detroit, MI) and had a stock concentration of 40 ppm
(1.785 lM) in nitrogen. Various volumes of H2S were injected
into the GC to generate a standard curve. For the quantifi-
cation of H2S in samples, 0.1 to 0.3ml of the gas phase from
the reaction mixture was injected into the GC. The amount of
H2S in the injected volume was calculated from the peak
areas by using the calibration coefficient obtained from the
standard curve. Accounting for the reaction volume gives
the total amount of H2S in the gas phase of the reaction
syringe. Dissolved H2S was calculated by multiplying the
concentration of H2S in the gas phase by 1.6, the ratio be-
tween the concentration of H2S in the gas and liquid phases
(11). The HS- ion concentration in the liquid phase was cal-
culated for pH 7.4 (the pH of the reaction mixture) by using
a pKa of 6.8 for ionization of H2S. The sum of H2S in both
phases produced in blank reactions lacking tissue was sub-
tracted from that of reactions containing tissue. The resulting
H2S concentration was then used to obtain the specific ac-
tivity for H2S production by dividing the net H2S produced
by the incubation time and by the amount of tissue.
Specific activity was expressed as nanomoles per minute per
milligram.
Results
Quantification of CBS and CSE protein levels
CBS and CSE protein levels in mouse liver (Fig. 2A and B)
and kidney (Fig. 3A and B) tissues were estimated by quan-
titative Western blot analysis, as described under Methods.
Quantification of the Western blot data revealed that CBS is
twofold higher, and CSE is sixfold higher in liver than in
kidney (Figs. 2C and 3C). In both tissues, CSE was signifi-
cantly more abundant than CBS;*60-fold higher in liver and
20-fold higher in kidney. The amount of CBS protein was
estimated to be 0.13 – 0.025 ng/lg of total protein in liver
lysate and 0.055– 0.026 ng/lg of total protein in kidney ly-
sate. For CSE, liver and kidney protein amounts were esti-
mated to be 8.0 – 0.4 and 1.26 – 0.04 ng/lg of total protein,
respectively. Although CBS and CSE antibodies highlighted
protein bands in brain samples, they exhibited aberrant mi-
gration (Fig. 4A and B). With CBS, in addition to a band of the
expected size, we also observed a band that was larger by
*20 to 30 kDa and one significantly smaller band (*35 kDa).
With CSE, we detected a single band, also of higher molec-
ular mass (*55 kDa). We noted that a higher than expected
molecular mass for CSE was previously reported, although
not discussed (31). Although the higher-molecular-mass
bands could represent modified forms of the protein [e.g.,
both CBS and CSE can be sumoylated (2,17)], in the absence
of further validation of the identities of the highlighted
bands, the brain Western data were not processed for quan-
titative analysis.
H2S production by liver
H2S was monitored by using a sulfur chemiluminescence
detector coupled to a gas chromatographer, as described
FIG. 2. Quantitative Western blot analysis of transsul-
furation pathway enzymes in liver. Representative Western
blot in which the indicated amounts of liver extract were
separated in parallel with known amounts of CBS (A) or CSE
(B). Quantitation of CBS and CSE protein levels in liver (C).
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previously (11). Because volatile sulfur-containing organic
compounds, such as carbonyl sulfide, methanethiol, and
dimethylsulfide, can be produced during H2S metabolism
(21), chromatographic conditions were used that yielded
excellent baseline separation of these compounds from H2S,
which eluted early at 1.1min (Fig. 5). However, none of the
compounds other than H2S was observed in our samples.
The detection limit for H2S under our experimental condi-
tions is*4 nM. The rate of H2S production was determined
in tissue homogenates in the presence of various concen-
trations of the substrates, cysteine and homocysteine (Fig.
6A and Table 1). The linear dependence of the assay on time
( £ 20min), on substrate (0.5 to 15mM), and on tissue protein
concentration, was established before measuring the rate of
tissue H2S generation. The background rate of desulfhy-
dration of cysteine and homocysteine was measured for
every substrate concentration used and subtracted from the
experimental value obtained in the presence of tissue ex-
tract. In the presence of saturating concentrations of cyste-
ine and homocysteine (20mM each), the rate of liver H2S
production was 1,191 – 133 nmole/min/g tissue at 37C
(Table 1). Addition of the irreversible inhibitor of CSE,
propargylglycine, reduced the rate of H2S production by
about twofold. When the H2S rate was measured in the
presence of either substrate alone, it was about threefold
lower: 407 – 67 nmole/min/g tissue in the presence of
20mM cysteine and 377 – 36 nmole/min/g tissue in the
FIG. 3. Quantitative Western blot analysis of the trans-
sulfuration pathway enzymes in kidney. Representative
Western blot in which the indicated amounts of kidney ex-
tract were separated in parallel with known amounts of CBS
(A) or CSE (B). Quantitation of CBS and CSE protein levels in
kidney (C).
FIG. 4. Western blot analysis of CBS (A) and CSE (B) in
brain. Representative Western blot for CBS contains, from
left to right, 0.1, 0.25, 0.5, and 1ng of purified CBS per lane
and 10, 20, and 40lg of total brain protein per lane. Re-
presentative Western blot for CSE contains, from left to right,
2.5, 5, and 10 ng of purified CSE per lane and 25, 50, and
100 lg of total brain protein per lane.
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presence of 20mM homocysteine. Propargylglycine in-
hibited H2S production > 90% when cysteine alone was
used as substrate and almost 100% when homocysteine
alone was used. As expected, lower rates of H2S production
were observed as the concentrations of cysteine and
homocysteine were decreased. H2S production increased
about twofold in the presence of AdoMet and propar-
gylglycine when either cysteine or cysteine+homocysteine
was used as a substrate (Fig. 6B).
H2S production in kidney
In kidney, the rate of H2S generation in the presence of
homocysteine and cysteine was 196.0– 3.6 nmole/min/g
tissue, which is sixfold lower than that in liver (Fig. 6C). H2S
generation from cysteine or homocysteine alone was reduced
approximately threefold (57– 8 and 60– 12 nmole/min/g
tissue, respectively). Addition of propargylglycine to kidney
extract reduced H2S production by 15% in the presence of
both substrates, and 40%when homocysteine was used alone.
Propargylglycine had no effect on H2S generation from
cysteine alone.
H2S production in brain
The rate of H2S generation in brain homogenate was sig-
nificantly lower compared with liver and kidney (15.3 –
2.2 nmole/min/g tissue in the presence of cysteine and
homocysteine) (Fig. 6D). When either cysteine or homo-
cysteine was used alone, the rate of H2S generation decreased
by fourfold and 23-fold, respectively (3.8 – 0.6 and 0.66 –
0.02 nmole/min/g tissue, respectively). Propargylglycine
did not reduce the rate of H2S production in brain extract
when either cysteine or cysteine + homocysteine was used
as substrates. In contrast, the rate of H2S production was
inhibited by about twofold in the presence of homocysteine
alone.
Discussion
Although the number of reports on the varied physiologic
effects of H2S continues to increase (4, 8, 24, 29), large gaps
remain in our understanding of fundamental aspects of H2S
metabolism. The balance between H2S generation by the
transsulfuration enzymes and clearance via a mitochondrial
catabolic pathway determines the steady-state tissue con-
centrations of H2S, which appear to be very low (11, 28). The
combined activities of cysteine aminotransferase and mer-
captopyruvate sulfur transferase generate sulfane sulfur,
which, in the presence of a reductant, can liberate H2S (16).
The physiologic relevance of this two-enzyme system in the
cysteine catabolic pathway in the presence of a coupled oxi-
doreductase, to H2S production remains to be established.
Assessment of the relative capacities for H2S production by
CBS and CSE requires information about their prevalence in
different tissues and about their relative abundance. How-
ever, reports on the relative levels of CBS and CSE and their
immunohistochemical localization are confounded by non-
quantitativeWestern blot data and by the use of commercially
available antibodies that exhibit cross-reactivity with other
proteins. In vitro kinetic analyses of the two major H2S gen-
erators, CBS and CSE, have led to simulations of the relative
contributions of each enzyme to H2S production at physio-
logically relevant substrate concentrations, assuming equi-
molar concentrations of each enzyme (7, 33). However, for the
simulations to have tissue relevance, the relative concentra-
tions of CBS and CSE in the tissue of interest is necessary. In
this study, we quantified CBS and CSE protein levels in liver
and kidney and analyzed their contributions to H2S genera-
tion in liver, kidney, and brain. Our results show that signif-
icant tissue-specific differences exist in the relative and
absolute levels of CBS and CSE and that these differences are
mirrored by differences in the H2S production capacity of
these tissues.
Quantitative Western blot analysis reveals that CBS levels
are about twofold higher in liver than in kidney, which is in
excellent agreement with the two- to threefold higher liver
CBS activity compared with kidney homogenates (9, 25, 37).
Similarly, the observed sixfold higher CSE in liver versus
kidney is in good agreementwith the approximately threefold
difference in CSE activity between these tissues (9, 25). As
discussed earlier, Western analyses detected the presence of
either multiple bands (for CBS) or a single high-molecular
band (with CSE) and were not subjected to quantitative
analysis because their identities of these bands were not
confirmed. A limitation of our study is that we used anti-
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FIG. 5. Gas chromatogram showing separation of sulfur
compounds (A) and standard curve for H2S generated by
injecting different amounts of H2S into the GC, as de-
scribed under Methods (B). (A) The following standards
were injected in a total volume of 200 ll: 1-H2S (2.7 ppm), 2-
COS (5 ppm), 3-CH3SH (5 ppm), 4-CH3CH2SH (5 ppm), and
5-CH3SCH3 (5 ppm), respectively, in nitrogen. The standards
were obtained from Cryogenic Gases (Detroit, MI).
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bodies generated against human CBS and CSE to detect and
quantitate the corresponding murine proteins. Human and
mouse CBS and CSE show 80% and 84% sequence identities,
respectively. Because the antibodies were raised against de-
natured proteins and are polyclonal, we do not expect dif-
ferences in reactivity to be large enough to negate our results.
Most studies evaluating H2S production in tissues use cys-
teine as the sole substrate (11, 23, 27). However, as expected
from detailed in vitro kinetic analyses with purified human
CBS and CSE (7, 33), and confirmed in this study (Table 1),
the sole use of cysteine leads to a significant underestimation
of the H2S-generation rate and biases the data toward
A B
C D
FIG. 6. H2S generation by murine tissues in the presence of different substrates. H2S production rates were measured in
liver (A, B), kidney (C), and brain (D) extract – 3mM propargylglycine, as described under Methods in the presence of either
20mM cysteine + 20mM homocysteine, 20mM cysteine, or 20mM homocysteine. When the effect of AdoMet (500lM) was
examined, all reaction mixtures contained 3mM propargylglycine to inhibit CSE. The control reaction mixture lacked tissue.
The data represent the mean– SD of three independent experiments.
Table 1. H2S Production Rates by Murine Tissues
Liver Kidney Brain Tissue-free blank
Substrate (mM) Nmol/min/g tissue Nmol/min/g tissue Nmol/min/g tissue Nmol/min/ml
Cys +Hcy
20 1,191 – 133 196.0– 3.6 15.3 – 2.2 0.024– 0.004
Cys
20 407 – 67 57– 8 3.8 – 0.6 0.002– 0.00014
10 294 – 89 33– 2 2.7 – 0.2 0.0014– 0.00013
5 182 – 17 23.0 – 1.7 1.4 – 0.1 –
1 38 – 6 10.9 – 0.8 0.35 – 0.02 –
Hcy
20 377 – 36 60– 12 0.66 – 0.02 0.024– 0.002
10 202 – 35 43– 6 0.47 – 0.1 0.01 – 0.003
5 79.4 – 0.1 29– 5 0.39 – 0.02 0.006– 0.002
1 9 – 2 14– 3 0.08 – 0.03 0.0022– 0.0004
Anaerobic incubation conditions were used in the assays, and the values are the mean– SD of three experiments. The tissue-free blank
values for H2S production were subtracted from the values obtained from the corresponding tissue-containing samples before conversion of
the rates into units of nanomoles per minute per gram of tissue, as described under Methods.
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CSE-dependent H2S production, particularly in liver. Further-
more, hydroxylamine is commonly used as a ‘‘specific’’ CBS
inhibitor (1, 23) although this compound has been historically
used to release the cofactor from PLP enzymes (34). Because
CBS and CSE are both PLP-dependent enzymes, the use of
hydroxylamine in an assay mixture inactivates both enzymes.
Given these limitationswith earlier estimations,wedetermined
tissue H2S production rates in the presence of one or both
substrates, cysteine and homocysteine, and in the presence or
absence of the CSE-specific inhibitor, propargylglycine.
H2S is redox active (16), and its catabolism is oxygen de-
pendent (5). Under aerobic conditions, steady-state H2S levels
reflect the difference between production and oxidation rates
and are negligible (11). Hence, our studies were conducted
under anaerobic conditions that inhibit sulfide oxidation. The
rate of H2S production by liver homogenates in the presence
of 20mM each of homocysteine and cysteine were sixfold and
79-fold higher compared with the rates in kidney and brain,
respectively. When cysteine is used, either alone or in com-
bination with homocysteine, H2S is generated by the activities
of both CSE and CBS, and deconvoluting the contributions of
the individual enzymes requires activity measurements in the
presence of the CSE inhibitor, propargylglycine, or in the
presence of homocysteine, which, by itself, is a substrate only
for CSE (33). Because propargylglycine inhibits CSE- but not
CBS-dependent H2S production, the*50% reduction in liver
H2S generation from cysteine and homocysteine observed in
the presence of propargylglycine indicates that CBS and CSE
contribute approximately equally to H2S production under
saturating substrate concentrations. H2S production by CBS
increased about twofold in the presence of AdoMet when
cysteine or cysteine +homocysteine was used as a substrate.
When either cysteine or homocysteine alone was used as
substrate, an *65% lower rate of H2S production was ob-
served, which was inhibited by 92% and 99.7%, respectively,
by propargylglycine. The almost complete inhibition by pro-
pargylglycine of H2S production from either substrate alone
indicates that CSE is the major catalyst for H2S formation
under these conditions and is consistent with the lack of
measureable AdoMet stimulation under these conditions (Fig.
6A and B). It also confirms the in vitro steady-state kinetic data
(33), which predict that the primary reaction catalyzed by CBS
under conditions of substrate saturation is the b-replacement
of cysteine by homocysteine (versus the alternative reactions,
b-replacement of cysteine by water and the condensation of
two moles of cysteine) (33).
For liver, assuming equimolar protein concentrations and
by using physiologically relevant concentrations of substrate,
the relative contributions to H2S production of CBS/CSE was
estimated to range from 1:3 to 7:3, depending on the magni-
tude of allosteric activation of CBS by AdoMet (33). The ob-
served contribution of hepatic CBS to H2S production from
cysteine alone (*8%) is in good agreement with the value of
2% estimated from the 60-fold lower CBS versus CSE protein
levels and their comparable catalytic efficiencies for cysteine-
dependent H2S production [kcat/Km for CBS and CSE are
0.08mM/s (7) and 0.07mM/s (33), respectively].
However, under cellular conditions, CBS and CSE are not
equally abundant. Applying the results from quantitative
Western blot analyses obtained in this study (Figs. 2C and 3C;
for example, CSE is 60-fold more abundant than CBS in liver),
we estimate that CBS accounts for only 3% of hepatic H2S
generation capacity (Fig. 7). This value is expected to be about
twofold lower in the complete absence of AdoMet activation.
Furthermore, as homocysteine concentrations increase to
levels seen in mild or severe forms of homocystinuria (20), the
relative contribution of CBS is predicted to diminish even
further. Thus, our analysis predicts that in liver, CSE accounts
for 97% to 99% of the H2S output over a homocysteine con-
centration range of 10 to 200 lM.
The picture for the relative H2S generation potential under
saturating substrate concentrations in kidney is quite different
from that in liver. Kidney H2S production was relatively in-
sensitive to propargylglycine, being reduced only 15% when
cysteine and homocysteine were simultaneously used as
substrates (Fig. 6C). This is consistent with CBS being the
major source of H2S in kidney. In the presence of either cys-
teine or homocysteine alone, H2S production was reduced
about threefold in comparison to the rate observed in the
presence of both substrates. Interestingly, whereas pro-
pargylglycine did not inhibit cysteine-dependent production
of H2S, it inhibited the homocysteine-dependent H2S pro-
duction rate by 1.6-fold. Renal cysteine concentration is high,
*1mM (35), which is *10-fold higher than that in liver
(60–180 lM), and in brain (50–120 lM) (35, 37). Hence, the
residual H2S production fromhomocysteine in the presence of
propargylglyine, observed in kidney but not in liver samples,
could be derived from the CBS-catalyzed b-replacement of
cysteine present in kidney extract, by homocysteine. The
greater relative importance of CBS for H2S production in
kidney versus liver can be explained at least in part by dif-
ferences in the relative expression levels of the transsulfura-
FIG. 7. Simulated contributions of fully activated CBS
and CSE to liver H2S production at physiologically rele-
vant substrate concentrations and varying grades of
hyperhomocysteinemia. The contributions of the transsul-
furation enzymes were estimated based on previously
reported simulations (33) and by taking into account the 1:60
ratio for CBS to CSE in mouse liver, as determined in this
study (Fig. 1). The substrate concentrations used for simu-
lation were 560lM serine, 100 lM cysteine, and varying
homocysteine [10 lM (normal), 40lM (mild hyperhomocys-
teinemia), and 200 lM (severe hyperhomocysteinemia)].
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tion enzymes in the two tissues. Thus, CSE is 60-fold higher
than CBS in liver but only 20-fold higher in kidney, resulting
in a threefold higher relative abundance of CBS in kidney than
in liver. Our results are consistent with an earlier study on the
protective effect of H2S on renal ischemia/reperfusion injury
that concluded that CBS is primarily responsible for H2S
generation in kidney (38).
Enzyme assays in rat tissue extracts estimate that CBS is
about fivefold less active (10), and CSE,*500-fold less active
(25) in brain than in liver. Based on these data, and assuming a
correspondence between protein level and enzyme activity,
CBS is predicted to be about twofoldmore abundant thanCSE
in rat brain, although for reasons discussed earlier, this could
not be assessed in the current study. The relative lack of
sensitivity of H2S production to propargylglycine, when
cysteine +homocysteine or cysteine alone was used as sub-
strate, indicates that the CBS is primary source of H2S in brain
(Fig. 6D). H2S production in the presence of homocysteine
accounted for only 4% of the rate observed in the presence of
cysteine +homocysteine and was largely inhibited by pro-
pargylglycine, supporting the conclusion that CSE is not a
significant source of brain H2S, even at saturating substrate
concentrations. This is consistent with brain H2S levels being
unchanged in CSE-knockout mice, whereas aorta and heart
H2S levels were decreased*80% (40).
In summary, we demonstrate that significant differences
exist between tissues in the relative contributions of CBS
versus CSE and in their net H2S-production capacity. The use
of multiple assay methods in the presence and absence of
AdoMet, the allosteric activator of CBS, and proparglygly-
cine, a CSE inhibitor, allows evaluation of the individual
contributions of the two enzymes to H2S generation. Extra-
polation of H2S output by CBS versus CSE in tissues requires
quantitative information on their protein levels and detailed
kinetic information on the H2S-generating reactions at phys-
iologically relevant substrate concentrations. We demonstrate
how adjusting for protein levels of CBS and CSE results in a
very different picture of their relative contributions to liver
H2S generation at physiologically relevant concentrations of
cysteine and homocysteine.
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CAT¼ cysteine aminotransferase
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GC¼ gas chromatography
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PLP¼pyridoxal-5¢-phosphate
PPG¼propargylglycine
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